z-logo
open-access-imgOpen Access
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
Author(s) -
Emanuele Andreano,
Giulia Piccini,
Danilo Licastro,
Lorenzo Casalino,
Nicole V. Johnson,
Ida Paciello,
Simeone Dal Monego,
Elisa Pantano,
Noemi Manganaro,
Alessandro Manenti,
Rachele Manna,
Elisa Casa,
Inesa Hyseni,
Linda Benincasa,
Emanuele Montomoli,
Rommie E. Amaro,
Jason S. McLellan,
Rino Rappuoli
Publication year - 2021
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2103154118
Subject(s) - virology , polyclonal antibodies , antibody , neutralizing antibody , immunity , convalescent plasma , biology , immune system , monoclonal antibody , population , covid-19 , neutralization , virus , vaccination , immunology , medicine , infectious disease (medical specialty) , disease , environmental health , pathology
To investigate the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the immune population, we coincupi bated the authentic virus with a highly neutralizing plasma from a COVID-19 convalescent patient. The plasma fully neutralized the virus for seven passages, but, after 45 d, the deletion of F140 in the spike N-terminal domain (NTD) N3 loop led to partial breakthrough. At day 73, an E484K substitution in the receptor-binding domain (RBD) occurred, followed, at day 80, by an insertion in the NTD N5 loop containing a new glycan sequon, which generated a variant completely resistant to plasma neutralization. Computational modeling predicts that the deletion and insertion in loops N3 and N5 prevent binding of neutralizing antibodies. The recent emergence in the United Kingdom, South Africa, Brazil, and Japan of natural variants with similar changes suggests that SARS-CoV-2 has the potential to escape an effective immune response and that vaccines and antibodies able to control emerging variants should be developed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here